Disclosure Panels Details Page
Neuroendocrine Tumors Panel - Disclosures as of 09/06/2013
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Al Benson III MD, FACCC, FACP, FASCO | Advanced Accelerator Applications SA Alchemia Limited Amgen Inc. Astellas Pharma US, Inc. Bayer HealthCare Genentech, Inc. Gilead Infinity Novartis Pharmaceuticals Corporation |
Bayer HealthCare Bristol Myers Squibb Cleveland Biolabs Eli Lilly and Company Genentech, Inc. Genomic Health, Inc. Gilead McKinsey National Cancer Institute Precision Therapeutics, Inc. Spectrum Pharmaceuticals |
None | None | ✔ |
| Emily Bergsland MD | Genentech, Inc. Lexicon Novartis Pharmaceuticals Corporation sanofi-aventis U.S. |
Novartis Pharmaceuticals Corporation | None | None | ✔ |
| Jordan Berlin MD | Abbott Laboratories Amgen Inc. Bayer HealthCare Genentech, Inc. ImClone Systems Incorporated Novartis Pharmaceuticals Corporation Pfizer |
AstraZeneca Pharmaceuticals LP Celgene Corporation Eli Lilly and Company Novartis Pharmaceuticals Corporation Roche Laboratories, Inc. symphogen |
None | None | ✔ |
| Lawrence Blaszkowsky MD | Genentech, Inc. GSK |
None | None | None | - |
| Jennifer Burns BS | None | None | None | None | - |
| Michael Choti | None | Bayer HealthCare Genentech, Inc. sanofi-aventis U.S. |
None | None | ✔ |
| Orlo Clark MD | Xoma | Xoma | None | None | - |
| Mary Dwyer MS | None | None | None | None | - |
| Lyska Emerson MD | None | None | None | None | ✔ |
| Paul Engstrom MD, FACP | None | None | None | None | ✔ |
| Paul Fanta MD | None | None | None | None | ✔ |
| Deborah Freedman-Cass PhD | None | None | None | None | - |
| Lauren Gallagher | None | None | None | None | - |
| Whitney Goldner MD | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Martin Heslin MD | None | None | None | None | - |
| Fouad Kandeel MD, PhD | None | None | None | None | - |
| Matthew Kulke MD, MMSc | None | Ipsen Lexicon Novartis Pharmaceuticals Corporation Pfizer Inc. |
None | None | ✔ |
| Pamela Kunz MD | Genentech, Inc. Merck & Co., Inc. sanofi-aventis U.S. |
None | None | None | - |
| Boris Kuvshinoff MD, MBA | None | None | None | None | - |
| Christopher Lieu MD | NA | NA | NA | NA | ✔ |
| Joan McClure MS | None | None | None | None | - |
| Jeffrey Moley MD | AstraZeneca Pharmaceuticals LP Exelixis Inc. |
Exelixis Inc. | None | None | ✔ |
| Gitonga Munene MD | None | None | None | None | ✔ |
| Venu Pillarisetty MD | None | None | None | None | ✔ |
| Leonard Saltz MD | Amgen Inc. Astellas Pharma US, Inc. Bayer HealthCare Biothera Bristol Myers Squibb CureTech Ltd. Eli Lilly and Company Genentech, Inc. ImClone Systems Incorporated Immunomedex National Cancer Institute OSI Pharmaceuticals, Inc. Pfizer Inc. Roche Laboratories, Inc. Synta Pharmaceuticals Corp. Taiho Pharmaceuticals Co., Ltd. |
Bayer HealthCare CureTech Ltd. Genentech, Inc. Genomic Health, Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. Roche Laboratories, Inc. Taiho Pharmaceuticals Co., Ltd. |
None | None | ✔ |
| Manisha Shah MD | National Cancer Institute Novartis Pharmaceuticals Corporation |
Novartis Pharmaceuticals Corporation | None | None | ✔ |
| Julie Ann Sosa MD | None | None | None | None | ✔ |
| Jonathan Strosberg MD | Genentech, Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. |
Genentech, Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. |
None | None | ✔ |
| Sarika Trikha PharmD | None | None | None | None | - |
| Jean-Nicolas Vauthey MD | None | None | None | None | - |
| James Yao MD | Genentech, Inc. Ipsen Lexicon National Cancer Institute Novartis Pharmaceuticals Corporation |
National Cancer Institute Novartis Pharmaceuticals Corporation Pfizer Inc. |
None | None | ✔ |